ScandiBio Therapeutics is a biotechnology company that develops AI-driven pharmaceutical drugs targeting mitochondrial dysfunction for the treatment of metabolic and neurodegenerative diseases
ScandiBio Therapeutics is a biotechnology company that develops AI-driven pharmaceutical drugs targeting mitochondrial dysfunction for the treatment of metabolic and neurodegenerative diseases.